OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Miles Wang, an OpenAI researcher specializing in AI-driven scientific discovery, is planning to depart the company to launch a startup focused on AI models for drug discovery. Reports indicate he is in discussions to raise approximately $200 million, potentially valuing the new venture at $2 billion, with Lightspeed potentially leading the funding round. The startup is reportedly exploring the repurposing of existing FDA-approved drugs. This move follows a broader industry trend of significant investor interest in applying AI to life sciences, as evidenced by recent large funding rounds for competitors like Chai Discovery and Isomorphic Labs.

(Source：TechCrunch)